Cancer Family
Head and Neck Melanocytic Neoplasm
CI-CAN-00000193Explore in graph →
Non-malignant3 active trials
- NCIt
- C173488
Loading cancer entity…
Cancer Family
CI-CAN-00000193Explore in graph →
Clinical trials
9 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05546827 | Preoperative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Mucosal Melanoma | recruiting | Phase 2 | 40 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 10, 2026 | clinicaltrials |
| NCT04318717 | Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma | recruiting | Phase 2 | 20 | Washington University School of MedicineOTHER | 1 | Aug 27, 2026 | clinicaltrials |
| NCT05111574 | Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery | active not recruiting | Phase 2 | 101 | National Cancer Institute (NCI)NIH | 2 | Aug 4, 2026 | clinicaltrials |
| NCT07662694 | CLASSIFY-OMM: Multicenter Rare Disease Cohort for T-Stage Reclassification and Molecular Subtyping-Based Precision Therapy in Oral Mucosal Melanoma |
Data updated 20 days agoSource updated Sep 10, 2026source: clinicaltrials
| not yet recruiting |
| — |
| 1,100 |
| Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityOTHER |
| 1 |
| Jun 23, 2026 |
| clinicaltrials |